NextCure exits remaining Beltsville lab space early, pays $0.8 million fee
The company terminated its lease for about 29,864 square feet in Beltsville, Maryland effective September 1, 2026, ahead of the original term.
NextCure, Inc. disclosed in an 8-K filing that on August 28, 2026, it signed a Ninth Amendment to its lease agreement with ARE-8000/9000/10000 Virginia Manor, LLC. The amendment covered the company's remaining approximately 29,864 rentable square feet of leased laboratory and office space at 8000 Virginia Manor Road, Beltsville, Maryland, under a lease originally dated January 30, 2019.1
Under the amendment, NextCure vacated and surrendered the premises effective August 31, 2026, and the parties agreed to accelerate the lease expiration, ending the company's future rent obligations effective September 1, 2026, subject to the amendment's terms.1
In connection with the amendment, NextCure paid a one-time termination fee of approximately $0.8 million and forfeited its security deposit of approximately $39,000.1
The filing lists the Ninth Amendment to the Lease Agreement, dated August 28, 2026, as an exhibit. The 8-K was signed by Steven P. Cobourn, Chief Financial Officer, and dated September 3, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.